With reference to Active Virosome Technology (AVT), consider following statements

1. It was developed by Seagull Bio is useful for the production of vaccines & immunotherapeutic agents.
2. AVT platform is useful for producing novel, non-hazardous & economical Active Virosome agents expressing desired antigens from the target pathogen.

Select the correct statement.

Recently, the Department of Science and Technology operating under Ministry of Science and Technology is to fund Seagull Biosolutions to develop Active Virosome vaccines and immunodiagnostic kits for COVID-19. 

• The above kits and vaccine has been developed by Seagull BioSolutions, a startup working on new biological technologies, being funded by the Department of Science and Technology (DST).
• Active Virosome Technology (AVT) developed by Seagull Bio is useful for the production of vaccines & immunotherapeutic agents.
• These will be used to develop a novel vaccine for the prevention of COVID-19 infection and also immunodiagnostic ELISA kits for COVID-19.
• Seagull Biobased out of Entrepreneurship Development Center (Venture Center), Pune, and supported under Seed Support System of the Technology Development Board (TDB), DST is producing two types of Active Virosome (AV) agents.
• One expressing S protein of COVID-19 (AV-S) and another one expressing structural proteins of COVID-19 (AV-SPs).

By: Shubham Tiwari